English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduMore than two-thirds of people taking blood thinners take direct oral anticoagulants, or DOACs, which are under- or over-prescribed in up to one in eight patients. A new study finds that most prescribing issues for DOACs occur after a provider writes the initial prescription. Researchers say the findings highlight why patients on DOACs need to be monitored consistently.
Tag: apixaban
Amiodarone used with anticoagulant therapy increases bleeding-related hospitalizations compared with flecainide or sotalol
A cohort study of more than 90,000 older adults diagnosed with atrial fibrillation (Afib) who were treated with anticoagulants found that treatment with amiodarone during apixaban or rivaroxaban use was associated with greater risk for bleeding-related hospitalizations compared to flecainide or sotalol. The findings are published in Annals of Internal Medicine
Apixaban vs. Warfarin in Patients with an On-X Mechanical Aortic Valve
Although the On-X aortic valve and apixaban have been approved for use by the U.S. Food and Drug Administration (FDA), they had not been approved to be used together. Between May 2020 and September 2022, the PROACT Xa randomized, multicenter, open-label trial compared the direct factor Xa inhibitor apixaban (Eliquis) with warfarin in patients with bileaflet carbon aortic valves.
High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients
High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.
Stroke, Clot Risk Halved in Heart Disease and Arrhythmia Patients Who Took Blood Thinners Apixaban Versus Rivaroxaban
The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease
Cost, bleeding cited as major reasons for not taking newer anti-coagulant as prescribed
People who are prescribed the anti-coagulant apixaban cite six major reasons for failing to adhere to their prescriptions, including cost and potential bleeding.
Two Blood Thinners at Once: More Risk with the Same Reward
For some patients, adding aspirin to a direct oral anticoagulant is an equation that rarely adds up.
Instrumentation Laboratory Receives US FDA Marketing Authorization for the First Apixaban Diagnostic Test
Instrumentation Laboratory Receives US FDA Marketing Authorization for the First Apixaban Diagnostic Test